Medical affairs sits at the intersection of science and commercial strategy, owning credible scientific exchange with HCPs and KOLs. This collection covers MSL field planning, data-driven prioritization of medical interactions, and strengthening evidence-based engagement. Learn how medical affairs teams use real-world data to decide where to go, who to meet, and what to share — maximizing the impact of every scientific touchpoint.
Medical affairs leads scientific engagement with HCPs and KOLs — communicating evidence, gathering insights, supporting clinical and educational initiatives, and acting as a credible scientific bridge between the company and the medical community.
Medical science liaisons use real-world data — publications, trials, procedure volumes, and affiliations — to prioritize which experts to engage, plan efficient field coverage, and tailor scientific discussions to each KOL’s focus.
Medical affairs focuses on non-promotional, peer-level scientific exchange and insight generation, while sales drives commercial adoption. Data helps both align on which HCPs matter without blurring their distinct roles.